CDSCO panel seeks additional data on Covovax from Serum Institute

New Delhi: An expert panel of India's Central Drug Authority, which recently reviewed Serum Institute's application seeking emergency authorisation of Covid-19 vaccine Covovax, has sought additional data from the firm, while noting the jab has not yet been approved in the country of origin, official sources said.The Serum Institute of India (SII) had put in an application to the Drugs...
New Delhi: An expert panel of India's Central Drug Authority, which recently reviewed Serum Institute's application seeking emergency authorisation of Covid-19 vaccine Covovax, has sought additional data from the firm, while noting the jab has not yet been approved in the country of origin, official sources said.
Read also: SII seeks DCGI nod to manufacture Covovax